المؤلفون: G Kohanbash, C Belka, RE Coleman, D Barba, JH Kim, H Burris, E Razis, C Sturiale, Lesniak, SA Grossman, B Dhokia, MP Gustafson, ZQ Han, P Traxler, AM Sandmair, LM DeAngelis, G Franceschi, P Msaouel, G Kaur, MJ Zhu, S Taillibert, I Yang, M Brown, AT Bruce, HP Kalofonos, T Todo, TC Liu, HS Hochster, KL Black, C Royce, D Fukumura, NL Spector, P Duic, MP Sayers, M Koslow, C Stanton, KL Fink, L Kim, JM Reid, AK Muhammad, JS Yu, AH Friedman, T Gohongi, KA Kreuzer, R Cozens, GP Dunn, DA Haas-Kogan, KB Hymes, JH Sampson, DD Song, RB Herberman, R Ramina, K Kawakami, GG Gomez, N Jelluma, E Galanis, SC Saris, S Thomas, Sy Lim, FM Iwamoto, AJ Grant, H Bender, W Xia, C Wallace, LH Merchant, S Kunwar, RD Schreiber, RE Merchant, AM Kaplan, Vivek Tandon, JS Hardwick, K Ballman, Berger, I Stroud, D Fabbro, JM Piepmeier, WK Yung, JC Hiserodt, K Moore, YB Wang, L Zhang, R Alemany, N Dmitrieva, HJ Choi, KM Kroeger, CD Stiles, D Schiff, LJ Old, JL Clarke, AL Asher, DV Woo, JL Mahaley, R Brandt, P Clement, JI Kreisberg, M Ehtesham, FK Miura, EM Hiesiger, I Cokgor, PY Wen, IK Na, C Crane, LB Nabors, HI Robins, HT Chung, G Ibrahim, NK Kim, A Arista, K Panageas, S Ahmad, RK Jain, KL Penne, JJ Vredenburgh, GD King, M Weller, CT Kuan, T Tihan, H Wakimoto, R Sakalas, CW Reynolds, JC Buckner, S Lassiter, HF Young, M Kioi, H Fukuhara, J Wykosky, MA Vogelbaum, TN Kreisl, H Okada, RE McLendon, V Jendrossek, CJ Wikstrand, P Puranen, M Puranen, W Xiong, Mahaley, YY Kim, C Sauvageot, JA Quinn, SR Husain, S Labropoulos, IF Pollack, CH Tung, J Laterra, JM Dowell, HS Friedman, A Desjardins, EC Dees, K Shah, BK Cho, C Valiengo Lda, GC Gonzalez, P Forsyth, M Assenberg, W Debinski, P Riva, JC Rodrigues, DA Eberhard, S Xia, SM Chang, Jy Yoo, J Hardcastle, CA Kruse, TJ Liu, R Weissleder, Jr MahaleyMS, D Snook, W Roth, Subhashree Mahapatra, M Frattarelli, KC Wang, FF Lang, KA Jaeckle, EA Chiocca, K Terada, C Gomez-Manzano, PR Lowenstein, JJ Kelly, SA Rosenberg, P Selviaridis, Prados, IV Ulasov, E Tyminski, S Sinha, RL Hayes, J Brueggen, T Kuroda, GJ Baker, J Sul, G Simpson, M Rackover, SK Kim, DD Bigner, S Desideri, K Hopkins, XO Breakefield, JN Rich, H Ikeda, M Kawakami, JM Bruner, M Rosenfeld, ND Arvold, PH Aguiar, LW Brady, D Morris, G Roldan, M Candolfi, S Kesari, B Seed, BH Joshi, M Holdhoff, RL Martuza, YG Kwon, SX Jiang, JT Kemshead, M Campone, NL Vujanovic, Y Chen, DA Reardon, TF Cloughesy, A Dispenzieri, M van den Bent, M Kossila, B Hildebrandt, EH Oldfield, S Puri, T Zhang, K Kurozumi, S Loimas, MK Wibowo, C Holder, EM Rosen, H Hurwitz, G Dresemann, EC Kim, H Assi, BL Liu, N Butowski, C Appelt, Groves, EJ Moore, SJ Han, CA Palmer, N Ramakrishna, J Emrich, MJ Maurer, RK Puri, JL Norris, P Waterman, J Clarke, S Piantadosi, T Peery, JF Curtin, LE Abrey, AS Chi, N Courtenay-Luck, A Hemingway, Y Saeki, AB Lassman, V Papanastassiou, J Boni, ED Day, E Hussain, C Miyamoto, AK Mahapatra, R Scholz, AT Parsa, RB Greeno, KL Low, T Mikkelsen, S Chang, C Sarkar, J Fueyo, DV Cramer, PR Allegrini, A Dowlati, DM Gibo, L Xu, M Dey, MM Ames, M Shaffrey, HA McDonald, SB Omay, TR Pawlikowska, RL Hamilton, D George, N Riva, Ashok Kumar Mahapatra, A Immonen, TA Mattei, M Bamberg, X Ye, B Woodhall

المصدر: Indian Journal of Neurosurgery, Vol 01, Iss 01, Pp 054-060 (2012)

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, medicine.medical_treatment, Genetic enhancement, lcsh:Surgery, Disease, 030105 genetics & heredity, lcsh:RC346-429, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Glioma, novel therapy, medicine, current studies, lcsh:Neurology. Diseases of the nervous system, Chemotherapy, business.industry, Standard treatment, Immunotherapy, malignant glioma, lcsh:RD1-811, medicine.disease, gene therapy, Oncolytic virus, Radiation therapy, business, 030217 neurology & neurosurgery

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831d1b23c52c18a1f1c51646572e45e9
http://www.thieme-connect.de/DOI/DOI?10.4103/2277-9167.94372

المؤلفون: Pi, Meneses, Le, Abrey, Ka, Hajjar, Sh, Gultekin, Rm, Duvoisin, Ki, Berns, Myrna Rosenfeld

المصدر: Europe PubMed Central

مصطلحات موضوعية: Umbilical Veins, Neovascularization, Pathologic, Brain Neoplasms, Microcirculation, Plasminogen, Glioma, Transfection, Peptide Fragments, Rats, Inbred F344, Recombinant Proteins, Cell Line, Rats, Animals, Humans, Female, Endothelium, Vascular, Cloning, Molecular, Cell Division, Cells, Cultured

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2a76bde2826d4d14c1581d57a81a8fcb
https://pubmed.ncbi.nlm.nih.gov/10589788

المؤلفون: Kurz SC; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Stammberger A; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Rosahl SK; Health and Medical University, Campus Helios Erfurt, Erfurt, Germany.; Department of Neurosurgery, Friedrich-Schiller-University Jena, Jena, Germany., Abrey LE; InCephalo Therapeutics, Allschwil, Switzerland., Albert NL; Department of Nuclear Medicine, LMU University Hospital, Ludwig-Maximilians-University, Munich, Germany., von Baumgarten L; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-University, Munich, Germany., Gempt J; Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center, Medical Faculty, Albert-Ludwigs-University Freiburg, Germany., Leidgens V; Novocure GmbH, Munich, Germany., McLean A; Department of Neurosurgery, Jena University Hospital, Jena, Germany., Renovanz M; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany., Schwarzenberger J; Novocure GmbH, Munich, Germany., Sevenich L; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany., Urbanic Purkart T; Department of Neurology and Department of Radiology-Division of Neuroradiology, Vascular and Interventional Neuroradiology, Medical University of Graz, Graz, Austria., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Helmholtz Zentrum München (HMGU), Oberschleißheim, Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Hegi M; Laboratory of Brain Tumour Biology and Genetics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Nowosielski M; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

المصدر: Neuro-oncology [Neuro Oncol] 2023 Dec 08; Vol. 25 (12), pp. 2302-2304.

نوع المنشور: Letter

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leadership* , Medical Oncology*/organization & administration , Neurology*/organization & administration, Humans

المؤلفون: Friedman HS; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Prados MD; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Wen PY; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Mikkelsen T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Schiff D; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Abrey LE; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Yung WKA; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Paleologos N; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Nicholas MK; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Jensen R; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Vredenburgh J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Huang J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Zheng M; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT., Cloughesy T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Nov 10; Vol. 41 (32), pp. 4945-4952.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Ellingson BM; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Neuroscience Interdepartmental PhD Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, California.; Department of Neurosurgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; UCLA Neuro-Oncology Program, University of California Los Angeles, Los Angeles, California.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Hagiwara A; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan., Morris CJ; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Medical Scientist Training Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Cho NS; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, California.; Medical Scientist Training Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Oshima S; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Sanvito F; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Oughourlian TC; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Neuroscience Interdepartmental PhD Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Telesca D; Department of Biostatistics, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Raymond C; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, University of California Los Angeles, Los Angeles, California.; Department of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Abrey LE; F. Hoffman-La Roche, Ltd., South San Francisco, California., Garcia J; F. Hoffman-La Roche, Ltd., South San Francisco, California., Aftab DT; Exelixis, Alameda, California., Hessel C; Exelixis, Alameda, California., Rachmilewitz Minei T; VBL Therapeutics, Modi'in, Israel., Harats D; VBL Therapeutics, Modi'in, Israel., Nathanson DA; Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts., Cloughesy TF; UCLA Neuro-Oncology Program, University of California Los Angeles, Los Angeles, California.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Oct 13; Vol. 29 (20), pp. 4186-4195.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Glioblastoma*/diagnostic imaging , Glioblastoma*/drug therapy , Brain Neoplasms*/diagnostic imaging , Brain Neoplasms*/drug therapy, Humans ; Bevacizumab/therapeutic use ; Angiogenesis Inhibitors/therapeutic use ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/drug therapy ; Irinotecan/therapeutic use ; Magnetic Resonance Imaging/methods

المؤلفون: Hagiwara A; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Radiology, Juntendo University School of Medicine, Tokyo, Japan., Schlossman J; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Shabani S; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Raymond C; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Tatekawa H; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Diagnostic and Interventional Radiology, Osaka City University Graduate School of Medicine, Osaka, Japan., Abrey LE; F. Hoffman-La Roche, Ltd., Basel, Switzerland., Garcia J; F. Hoffman-La Roche, Ltd., Basel, Switzerland., Chinot O; Aix-Marseille University, AP-HM, Service de Neuro-Oncologie, CHU Timone, Marseille, France., Saran F; The Royal Marsden NHS Foundation Trust, Sutton, UK., Nishikawa R; Saitama Medical University, Saitama, Japan., Henriksson R; Regional Cancer Center Stockholm, Stockholm, Sweden.; Umeå University, Umeå, Sweden., Mason WP; Princess Margaret Hospital, Toronto, Canada., Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Cloughesy TF; UCLA Brain Research Institute (BRI), David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Ellingson BM; UCLA Brain Tumor Imaging Laboratory (BTIL), Center for Computer Vision and Imaging Biomarkers, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; Deptartment of Radiological Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; UCLA Brain Research Institute (BRI), David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; UCLA Neuro-Oncology Program, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; Department of Physics and Biology in Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.; Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA. bellingson@mednet.ucla.edu.

المصدر: Journal of neuro-oncology [J Neurooncol] 2022 Sep; Vol. 159 (3), pp. 509-518. Date of Electronic Publication: 2022 Jul 17.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/diagnostic imaging , Brain Neoplasms*/therapy , Glioblastoma*/diagnostic imaging , Glioblastoma*/therapy, Chemoradiotherapy/methods ; Disease Progression ; Humans ; Incidence ; Magnetic Resonance Imaging ; Reactive Oxygen Species

المؤلفون: Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA. Electronic address: rrahman@bwh.harvard.edu., Ventz S; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T H Chan School of Public Health, Boston, MA, USA., McDunn J; Project Data Sphere, Morrisville, NC, USA., Louv B; Project Data Sphere, Morrisville, NC, USA., Reyes-Rivera I; F Hoffmann-La Roche, Basel, Switzerland., Polley MC; Department of Public Health Sciences, University of Chicago, Chicago, IL, USA., Merchant F; Medicenna Therapeutics, Toronto, ON, Canada., Abrey LE; Novartis, Basel, Switzerland., Allen JE; Chimerix, Durham, NC, USA., Aguilar LK; Candel Therapeutics, Needham, MA, USA., Aguilar-Cordova E; Candel Therapeutics, Needham, MA, USA., Arons D; National Brain Tumor Society, Newton, MA, USA., Tanner K; National Brain Tumor Society, Newton, MA, USA., Bagley S; Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Khasraw M; Department of Neurosurgery, Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC, USA., Cloughesy T; Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard T H Chan School of Public Health, Boston, MA, USA., Alexander BM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, MA, USA; Foundation Medicine, Cambridge, MA, USA., Trippa L; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T H Chan School of Public Health, Boston, MA, USA.

المصدر: The Lancet. Oncology [Lancet Oncol] 2021 Oct; Vol. 22 (10), pp. e456-e465.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Controlled Clinical Trials as Topic* , Medical Oncology* , Neurology* , Research Design*, Antineoplastic Agents/*therapeutic use , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy, Antineoplastic Agents/adverse effects ; Brain Neoplasms/pathology ; Glioblastoma/pathology ; Humans ; Information Dissemination ; Treatment Outcome

المؤلفون: Chen H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Kuhn J; Division of Pharmacology, University of Texas, San Antonio, Texas, USA., Lamborn KR; Department of Neurological Surgery, University of California, San Francisco, California, USA., Abrey LE; Memorial Sloan Kettering Cancer Center, New York, New York, USA., DeAngelis LM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Lieberman F; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Robins HI; Departments of Medicine, Human Oncology, and Neurology, University of Wisconsin-Madison, Madison, Wisconsin, USA., Chang SM; Department of Neurological Surgery, University of California, San Francisco, California, USA., Yung WKA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Drappatz J; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA., Mehta MP; Department of Radiation Oncology, Miami Cancer Institute, Miami, Florida, USA., Levin VA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Dancey JE; Queen's University, Kingston, Ontario, Canada., Wright JJ; Investigational Drug Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA., Prados MD; Department of Neurological Surgery, University of California, San Francisco, California, USA., Cloughesy TF; Department of Neurology, University of California, Los Angeles, Los Angeles, California, USA., Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2020 Sep 17; Vol. 2 (1), pp. vdaa124. Date of Electronic Publication: 2020 Sep 17 (Print Publication: 2020).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Kaley TJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Panageas KS; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Pentsova EI; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Mellinghoff IK; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Nolan C; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Gavrilovic I; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Abrey LE; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Holland EC; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, New York., Omuro A; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York., Lacouture ME; Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York., Ludwig E; Gastroenterology and Nutrition Service, Memorial Sloan Kettering Cancer Center, New York, New York., Lassman AB; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, New York.

المصدر: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Apr; Vol. 7 (4), pp. 429-436. Date of Electronic Publication: 2020 Apr 15.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2328-9503 (Electronic) Linking ISSN: 23289503 NLM ISO Abbreviation: Ann Clin Transl Neurol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*administration & dosage , Brain Neoplasms/*drug therapy , Glioblastoma/*drug therapy , Phosphorylcholine/*analogs & derivatives , Sirolimus/*analogs & derivatives, Adult ; Aged ; Antineoplastic Agents/adverse effects ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Phosphorylcholine/administration & dosage ; Phosphorylcholine/adverse effects ; Prospective Studies ; Proto-Oncogene Proteins c-akt/antagonists & inhibitors ; Sirolimus/administration & dosage ; Sirolimus/adverse effects ; TOR Serine-Threonine Kinases/antagonists & inhibitors ; Young Adult

المؤلفون: Correa DD; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA. corread@mskcc.org.; Department of Neurology, Weill Cornell Medical College, New York, NY, USA. corread@mskcc.org., Braun E; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Kryza-Lacombe M; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, CA, USA., Ho KW; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA., Reiner AS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Panageas KS; Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Yahalom J; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sauter CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abrey LE; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Novartis Oncology, Basel, Switzerland., DeAngelis LM; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Department of Neurology, Weill Cornell Medical College, New York, NY, USA., Omuro A; Department of Neurology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA.; Yale Cancer Center and Department of Neurology, Yale School of Medicine, New Haven, CT, USA.

المصدر: Journal of neuro-oncology [J Neurooncol] 2019 Sep; Vol. 144 (3), pp. 553-562. Date of Electronic Publication: 2019 Aug 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Central Nervous System Neoplasms/*therapy , Cognition/*physiology , Cranial Irradiation/*methods , Hematopoietic Stem Cell Transplantation/*methods , Induction Chemotherapy/*methods , Lymphoma/*therapy, Adult ; Aged ; Central Nervous System Neoplasms/pathology ; Central Nervous System Neoplasms/psychology ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Longitudinal Studies ; Lymphoma/pathology ; Lymphoma/psychology ; Male ; Middle Aged ; Prognosis ; Quality of Life ; Survival Rate ; Transplantation, Autologous ; Young Adult